omega-n-methylarginine has been researched along with Cardiac Failure in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 26 (44.83) | 18.2507 |
2000's | 25 (43.10) | 29.6817 |
2010's | 7 (12.07) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Liu, X; Shang, R; Xu, X | 1 |
Katsurada, K; Knuepfer, MM; Liu, X; Patel, KP; Zheng, H | 1 |
Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Starklint, J | 1 |
Chen, A; Chen, Y; Fassett, JT; Hou, L; Liu, X; Xu, D; Xu, Y; Yang, L; Zhuang, Y | 1 |
Ishibashi, Y; Karino, K; Kodani, N; Kunizawa, Y; Murakami, Y; Oyake, N; Sakane, T; Sato, H; Shimada, T; Sugamori, T; Takahashi, N; Tokumaru, A; Yoshitomi, H | 1 |
Li, YF; Mehta, PP; Patel, KP; Sharma, NM; Zheng, H | 1 |
Patel, KP; Xu, B; Zheng, H | 1 |
Alves, MJ; Brum, PC; dos Santos, MR; Martinez, DG; Middlekauff, HR; Nazaré Nunes Alves, MJ; Negrão, CE; Nobre, TS; Pereira Barretto, AC; Rondon, MU | 1 |
Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Kunizawa, Y; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Oyake, N; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N | 1 |
Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
Hirooka, Y; Kimura, Y; Kishi, T; Shigematsu, H; Takeshita, A; Ueta, Y | 1 |
Broadley, AJ; Cockcroft, JR; Frenneaux, MP; Gunaruwan, P; Lee, L; Nightingale, AK; Payne, N; Schmitt, M; Struthers, AD; Taylor, J; Tyberg, JV | 1 |
Ikeoka, K; Koida, S; Ohyanagi, M; Takahashi, K; Ueda, A | 1 |
Cornish, KG; Li, YF; Patel, KP; Zheng, H; Zucker, IH | 1 |
Adding, C; Bredin, F; Franco-Cereceda, A; Holm, P | 1 |
Mak, S; Newton, GE; Overgaard, CB | 1 |
Chia, S; Cruden, NL; Dover, AR; Ferguson, JW; Fox, KA; Megson, IL; Newby, DE | 1 |
Hata, K; Hirata, K; Kijima, Y; Masai, H; Murata, T; Ohta, S; Shinke, T; Shite, J; Takaoka, H; Yokoyama, M; Yoshikawa, R | 1 |
Burnett, JC; Chen, HH; Jougasaki, M; Martin, FL; Matsuda, Y; Sandberg, SM; Supaporn, T | 1 |
Keogh, AM; Macdonald, PS; Schyvens, CG; Smythe, GA; Spratt, PM; Winlaw, DS | 1 |
Cleland, JG; Crossman, D; Dutka, D; Habib, F; Oakley, CM | 1 |
Calver, A | 1 |
Arakawa, N; Funakoshi, T; Hiramori, K; Makita, S; Nakamura, M; Yoshida, H | 1 |
Bank, AJ; Beardslee, M; Garr, MD; Kraemer, MD; Kubo, SH; Raij, L; Rector, TS; Tadros, P | 1 |
McMurray, JJ; Webb, DJ | 1 |
Brunner, HR; Drexler, H; Hayoz, D; Just, H; Münzel, T; Zelis, R | 1 |
Burnett, JC; Miller, VM; O'Murchu, B; Perrella, MA | 1 |
Drexler, H; Hornig, B; Maier, V | 1 |
Charles, CJ; Fitzpatrick, MA; Frampton, CM; Ikram, H; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
Katz, SD; Khan, T; Knecht, M; Krum, H | 1 |
Blaise, G; Vallieres, Y; van Obbergh, L | 1 |
Hirooka, Y; Imaizumi, T; Takeshita, A | 1 |
Bank, AJ; Kubo, SH; Lin, KA; Mullen, KA; Rector, TS; Tschumperlin, LK | 1 |
Egashira, K; Harasawa, Y; Kuga, T; Mohri, M; Shimokawa, H; Tagawa, H; Tagawa, T; Takeshita, A | 1 |
Hasenfuss, G; Just, H | 1 |
Ishiwata, T; Kawahara, K; Naito, Z; Nishigaki, R | 1 |
Banning, AP; Brunini, TM; Conway, M; Ellory, JC; Hanssen, H; Mann, GE; Mendes Ribeiro, AC; Roberts, NB | 1 |
Cranswick, N; Krum, H; Pellizzer, AM | 1 |
Cooper, CJ; Dickinson, J; Jevnikar, FW; Mouhaffel, A; Selwyn, AP; Walsh, T | 1 |
Bank, AJ; Chuang, PP; Mullen, K; Shammas, RA | 1 |
Brodde, OE; Drexler, H; Hasenfuss, G; Kästner, S; Strobel, A; Studer, R | 1 |
Adnot, S; Benacerraf, S; Calvo, F; Carville, C; Castaigne, A; de Cremou, P; Dubois-Randé, JL; Sediame, S | 1 |
Johnston, GD; Maguire, SM; McGurk, C; Nicholls, DP; Nugent, AG | 1 |
Akatsu, T; Arakawa, N; Hiramori, K; Nakamura, M; Yoshida, H | 1 |
Farquharson, CA; Struthers, AD | 1 |
Hata, K; Kawai, H; Kijima, Y; Murata, T; Okubo, H; Shinke, T; Takaoka, H; Takeuchi, M; Yokoyama, M | 1 |
Hirano, Y; Inoue, SI; Ishibashi, Y; Murakami, Y; Nakamura, K; Ohata, S; Sakane, T; Shimada, T; Sugamori, T; Takahashi, N | 1 |
Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Ohhata, S; Sakane, T; Sano, K; Shimada, T; Sugamori, T; Takahashi, N | 1 |
Gutterman, DD; Liu, Y; Loberiza, F; Miura, H; Terata, K | 1 |
Arimura, K; Egashira, K; Ide, T; Nakamura, R; Shimokawa, H; Takeshita, A; Tsutsui, H | 1 |
Blackman, DJ; Ellis, GR; Frenneaux, MP; Jones, EA; Morris-Thurgood, JA; Nightingale, AK; Schmitt, M | 1 |
Katz, SD; Krum, H | 1 |
Li, YF; Patel, KP; Zhang, K | 1 |
Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N | 1 |
Frantz, S; Kelly, RA; Paulus, WJ | 1 |
Arimura, K; Egashira, K; Ide, T; Machida, Y; Nakamura, R; Shimokawa, H; Takeshita, A; Tsutsui, H | 1 |
Chowdhary, S; Coote, JH; Ng, GA; Nuttall, SL; Ross, HF; Townend, JN | 1 |
Brunner, HR; Drexler, H; Hayoz, D; Hornig, B; Just, H; Münzel, T; Zelis, R | 1 |
4 review(s) available for omega-n-methylarginine and Cardiac Failure
Article | Year |
---|---|
Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
Topics: Amidohydrolases; Animals; Arginine; Endothelium, Vascular; Heart Failure; Humans; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Insufficiency, Chronic; Risk Factors; Signal Transduction | 2018 |
Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Topics: Amidohydrolases; Animals; Arginine; Heart Failure; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peroxynitrous Acid; Signal Transduction; Superoxides | 2016 |
Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
Topics: Arginine; Chronic Disease; Endothelium, Vascular; Heart Failure; Humans; In Vitro Techniques; Nitric Oxide; omega-N-Methylarginine | 1994 |
[Expression of nitric oxide synthase and its effects on heart failure].
Topics: Animals; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Heart Failure; Humans; Macrophages; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 1997 |
9 trial(s) available for omega-n-methylarginine and Cardiac Failure
Article | Year |
---|---|
Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Blood Flow Velocity; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Vascular Resistance | 2013 |
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
Topics: Acetylcholine; Arginine; Aspirin; Enalaprilat; Endothelium, Vascular; Female; Forearm; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Plethysmography; Premedication; Vasodilation | 1994 |
Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Analysis of Variance; Arginine; Brachial Artery; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Exercise; Exercise Therapy; Female; Forearm; Hand Strength; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Muscle Contraction; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vascular Resistance; Vasodilation; Vasodilator Agents | 1998 |
Relation between impairment in nitric oxide pathway and clinical status in patients with congestive heart failure.
Topics: Acetylcholine; Enzyme Inhibitors; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Nitroprusside; omega-N-Methylarginine; Plethysmography; Severity of Illness Index; Vasodilation; Vasodilator Agents | 1998 |
Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent.
Topics: Aged; Aged, 80 and over; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Serotonin; Vasodilator Agents | 1998 |
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.
Topics: Aged; Angiotensin I; Angiotensin II; Chronic Disease; Cross-Over Studies; Diuretics; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Spironolactone; Vasodilation | 2000 |
Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Volume; Cardiomyopathy, Dilated; Diastole; Dobutamine; Energy Metabolism; Enzyme Inhibitors; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Pulmonary Wedge Pressure; Systole | 2000 |
Impaired vasodilatation response to amrinone in the forearm of patients with congestive heart failure: role of endothelium-derived nitric oxide.
Topics: Acetylcholine; Aged; Amrinone; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroglycerin; omega-N-Methylarginine; Regional Blood Flow; Vasodilator Agents | 2000 |
45 other study(ies) available for omega-n-methylarginine and Cardiac Failure
Article | Year |
---|---|
Specific Afferent Renal Denervation Prevents Reduction in Neuronal Nitric Oxide Synthase Within the Paraventricular Nucleus in Rats With Chronic Heart Failure.
Topics: Afferent Pathways; Animals; Capsaicin; Chronic Disease; Denervation; Enzyme Inhibitors; Heart Failure; Kidney; Male; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats, Sprague-Dawley; Sensory System Agents; Sympathetic Nervous System | 2018 |
Activation of inducible NOS in peripheral vessels and outcomes in heart failure patients.
Topics: Acetylcholine; Aged; Blood Flow Velocity; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; Enzyme Activation; Female; Follow-Up Studies; Forearm; Guanidines; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase Type II; Nitroglycerin; omega-N-Methylarginine; Prospective Studies; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Heart Failure; Hemodynamics; Immunohistochemistry; Kidney; Losartan; Male; Microinjections; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, N-Methyl-D-Aspartate; RNA Interference; RNA, Messenger; Sympathetic Nervous System; Time Factors | 2011 |
Enhanced activation of RVLM-projecting PVN neurons in rats with chronic heart failure.
Topics: 2-Amino-5-phosphonovalerate; Animals; Chronic Disease; Coronary Vessels; Electric Stimulation; Electrophysiological Phenomena; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Extracellular Space; Heart Failure; Ligation; Male; Medulla Oblongata; Midline Thalamic Nuclei; N-Methylaspartate; Neurons; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Osmolar Concentration; Pressoreceptors; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 2012 |
Mechanisms of blunted muscle vasodilation during peripheral chemoreceptor stimulation in heart failure patients.
Topics: Adult; Ascorbic Acid; Case-Control Studies; Chemoreceptor Cells; Forearm; Heart Failure; Hemodynamics; Humans; Hypoxia; Middle Aged; Muscle, Smooth, Vascular; omega-N-Methylarginine; Oxidative Stress; Phentolamine; Regional Blood Flow; Sympathetic Nervous System; Vasoconstriction; Vasodilation | 2012 |
Increased nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy: close correlation of tumor necrosis factor-alpha with systemic and local production of nitric oxide.
Topics: Adult; Aged; Arm; Cardiomyopathy, Dilated; Case-Control Studies; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; omega-N-Methylarginine; Tumor Necrosis Factor-alpha; Vasoconstriction | 2002 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
Reduced nitric oxide synthase in the brainstem contributes to enhanced sympathetic drive in rats with heart failure.
Topics: Animals; Blood Pressure; Blotting, Western; Brain Stem; Disease Models, Animal; Echocardiography; Gene Expression; Heart Failure; Hemodynamics; In Situ Hybridization; Injections, Intraventricular; Male; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Norepinephrine; omega-N-Methylarginine; Organ Size; Rats; Rats, Inbred WKY; RNA, Messenger; Solitary Nucleus; Sympathetic Nervous System | 2003 |
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Injections, Intra-Arterial; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Peptide Fragments; Tetrahydroisoquinolines; Vascular Resistance; Vasodilation; Veins | 2004 |
Variations of endothelium-dependent vasoresponses in congestive heart failure.
Topics: Acetylcholine; Animals; Bradykinin; Coronary Vessels; Endothelium, Vascular; Heart Failure; Hemodynamics; In Vitro Techniques; Male; Muscle, Skeletal; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Inbred WKY; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure.
Topics: Animals; Biomarkers; Blotting, Western; Enzyme Inhibitors; Heart Failure; Male; Microinjections; NADPH Dehydrogenase; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sympathetic Nervous System | 2005 |
Attenuation of postoperative noradrenaline need by nitric oxide inhibition using L-NMMA.
Topics: Blood Pressure; Contraindications; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Middle Aged; Mitral Valve Insufficiency; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Postoperative Period; Vasoconstrictor Agents | 2005 |
Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.
Topics: Aged; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase Type II; Norepinephrine; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasoconstrictor Agents | 2006 |
Inhibition of endogenous nitric oxide synthase augments contractile response to adenylyl cyclase stimulation without altering mechanical efficiency in patients with idiopathic dilated cardiomyopathy.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Aged; Biomechanical Phenomena; Cardiomyopathy, Dilated; Colforsin; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide Synthase Type III; omega-N-Methylarginine | 2007 |
Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure.
Topics: Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Guanylate Cyclase; Heart Failure; Kidney; Male; omega-N-Methylarginine; Polysaccharides | 2007 |
Nitric oxide production and heart failure.
Topics: Arginine; Heart Failure; Humans; Nitrates; Nitric Oxide; omega-N-Methylarginine; Vascular Resistance; Vasoconstriction | 1995 |
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?
Topics: Aged; Arginine; Cardiac Output, Low; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Vasodilation | 1994 |
Enhanced basal nitric oxide production in heart failure.
Topics: Arginine; Heart Failure; Hemodynamics; Humans; Nitric Oxide; omega-N-Methylarginine | 1994 |
Lack of contribution of nitric oxide to basal vasomotor tone in heart failure.
Topics: Adult; Aged; Arginine; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vascular Resistance | 1994 |
Enhanced basal nitric oxide production in heart failure.
Topics: Arginine; Heart Failure; Humans; Nitric Oxide; omega-N-Methylarginine; Vascular Resistance | 1994 |
Increased production of nitric oxide in coronary arteries during congestive heart failure.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arginine; Atrial Natriuretic Factor; Azepines; Blood Pressure; Calcimycin; Cardiac Output; Coronary Vessels; Dinoprost; Dogs; Endothelium, Vascular; Femoral Artery; Heart Failure; Hemodynamics; In Vitro Techniques; Indomethacin; Isometric Contraction; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Pertussis Toxin; Reference Values; Renal Artery; Renin; Vascular Resistance; Virulence Factors, Bordetella | 1994 |
Physical training improves endothelial function in patients with chronic heart failure.
Topics: Adult; Arginine; Chronic Disease; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Physical Education and Training; Regional Blood Flow | 1996 |
Nitric oxide inhibition in an ovine model of heart failure.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Heart Failure; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Sheep | 1996 |
Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide.
Topics: Adult; Aged; Arginine; Blood Flow Velocity; Blood Pressure; Exercise Test; Female; Forearm; Hand Strength; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasodilation | 1996 |
Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related.
Topics: Animals; Ascites; Cardiac Output; Coronary Vessels; Enzyme Inhibitors; Heart Failure; Liver Cirrhosis, Biliary; Male; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 1996 |
Role of endothelium in control of forearm blood flow in patients with heart failure.
Topics: Acetylcholine; Adult; Aged; Arginine; Endothelium, Vascular; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vascular Resistance; Vasodilator Agents; Vasomotor System | 1996 |
Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
Topics: Adult; Aspirin; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Renal Agents; Vasodilation | 1996 |
Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure.
Topics: Adult; Aged; Analysis of Variance; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Coronary Vessels; Data Interpretation, Statistical; Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Ventricular Function, Left | 1997 |
International Gargellen Conference.
Topics: Adrenergic beta-Antagonists; Calcium; Cardiac Glycosides; Enzyme Inhibitors; Heart; Heart Failure; Heart Rate; Humans; Myocardial Contraction; omega-N-Methylarginine; Sarcoplasmic Reticulum | 1997 |
Increased L-arginine transport in human erythrocytes in chronic heart failure.
Topics: Amino Acids; Arginine; Biological Transport; Chromatography, High Pressure Liquid; Erythrocytes; Ethylmaleimide; Heart Failure; Humans; Nitric Oxide Synthase; omega-N-Methylarginine | 1998 |
Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
Topics: Acetylcholine; Adult; Endothelin-1; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Hyperemia; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Regional Blood Flow; Stimulation, Chemical; Vasoconstriction; Vasoconstrictor Agents | 1998 |
The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Pulmonary Circulation; Vascular Resistance | 1998 |
Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Topics: Adrenergic beta-Agonists; Enzyme Inhibitors; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Polymerase Chain Reaction; Stimulation, Chemical; Transcription, Genetic | 1998 |
Effects of nitric oxide inhibition on basal forearm blood flow in patients with nonischemic chronic heart failure.
Topics: Blood Flow Velocity; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Reproducibility of Results; Vascular Resistance | 1998 |
Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; Muscle Tonus; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Severity of Illness Index; Vasomotor System | 2000 |
Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels.
Topics: Adenine; Adrenomedullin; Aged; Arterioles; Calcitonin Gene-Related Peptide; Coronary Circulation; Coronary Disease; Coronary Vessels; Enzyme Inhibitors; Female; Heart Failure; Humans; Hypertension; In Vitro Techniques; Male; Microcirculation; Middle Aged; Miotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Peptide Fragments; Potassium Channels; Vasodilation; Vasodilator Agents | 2000 |
Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcholine; Animals; Coronary Vessels; Dogs; Echocardiography; Electric Stimulation; Endothelium, Vascular; Enzyme Inhibitors; Free Radicals; Heart Failure; Hemodynamics; Immunohistochemistry; Indicators and Reagents; Lipid Peroxidation; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine | 2001 |
Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction.
Topics: Aged; Arteries; Carbachol; Chronic Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Vascular Capacitance; Vasodilation; Veins | 2001 |
Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.
Topics: Acetylcholine; Adult; Aged; Biological Factors; Brachial Artery; Case-Control Studies; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Indomethacin; Infusions, Intra-Arterial; Male; Middle Aged; Nitroglycerin; omega-N-Methylarginine; Plethysmography; Vasodilation; Vasodilator Agents | 2001 |
Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Heart Rate; Kidney; Ligation; Male; Microinjections; Neural Inhibition; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2001 |
An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
Topics: Acetylcholine; Adult; Aged; Analysis of Variance; Atrial Natriuretic Factor; Blood Flow Velocity; Case-Control Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Endothelium, Vascular; Female; Forearm; Guanidines; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Severity of Illness Index; Time Factors; Vasodilation | 2001 |
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left | 2001 |
Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Adenosine; Animals; Coronary Circulation; Dogs; Echocardiography; Endothelium, Vascular; Enzyme Inhibitors; Heart Failure; Hyperemia; Immunohistochemistry; Indicators and Reagents; Lipid Peroxidation; Myocardium; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pacemaker, Artificial; Reactive Oxygen Species; Tachycardia; Vasodilator Agents | 2001 |
Nitric oxide and cardiac parasympathetic control in human heart failure.
Topics: Adult; Aged; Baroreflex; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Enzyme Inhibitors; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Parasympathetic Nervous System; Phenylephrine; Single-Blind Method; Vasoconstrictor Agents | 2002 |
Endothelial function in chronic congestive heart failure.
Topics: Acetylcholine; Adult; Arginine; Blood Flow Velocity; Brachial Artery; Chronic Disease; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; omega-N-Methylarginine; Radius; Regional Blood Flow; Ultrasonography; Vascular Resistance; Vasodilation; Vasomotor System | 1992 |